cyclosporine · Abbvie · NDA 050790
Restasis Multidose
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050790 · 002 · RLD | emulsion, ophthalmic | 0.05% | open |
Expired or delisted (4)
- US 9669974 · product · 11 May 2034 · delisted
- US 9676525 · product · 7 Feb 2034 · delisted
- US 8561859 · product · 16 Apr 2032 · delisted
- US 8292129 · product · 25 Feb 2031 · delisted